AMGTA Releases Independent Report on Additive Manufacturing's Role in Resource-Efficient Manufacturing Systems
15.4.2026 13:59:00 CEST | Business Wire | Press Release
Following its 2026 Annual Member Summit, AMGTA today released Additive Manufacturing in Resource-Efficient Manufacturing Systems, an independent report establishing how additive manufacturing should be evaluated, communicated, and deployed across part, system, and enterprise levels.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415976875/en/
The report establishes a structural argument for how additive manufacturing should be evaluated — not at the part level alone, but across part, system, and enterprise levels where AM's most significant advantages in resource efficiency, supply chain resilience, and capital allocation actually materialize. It draws on six years of sustained observation across both sides of the AM ecosystem — technology developers and manufacturing users — producing findings that neither side could reach from its own position. It is designed for use in investor presentations, policy discussions, procurement conversations, and organizational decision-making.
The report was presented to and discussed with AMGTA's global membership at the 2026 Annual Member Summit, held April 13 in Boston, alongside the companion Strategy 2030 document.
Standard cost comparisons of additive manufacturing against conventional manufacturing capture the same direct production costs on both sides while systematically excluding costs that conventional manufacturing embeds as invisible background — tooling capital committed before demand is known, inventory carrying costs, minimum order quantity waste, and obsolescence write-offs. The result is a structural bias that makes AM appear more expensive than a complete evaluation would show.
The report identifies this as a framing and measurement problem, not a technology problem, and provides the evaluative structure organizations need to conduct complete comparisons across all three levels at which AM creates value.
As the only global, independent organization focused exclusively on the intersection of additive manufacturing and resource-efficient manufacturing systems — with no equipment to sell, no materials to promote, and no national interest to advance — AMGTA occupies a structural position no other organization holds. This report could not have been produced by a technology provider without reading as advocacy, or by a manufacturer without reading as justification. It required the vantage point of both sides simultaneously.
“The technology is proven. But the current adoption curve doesn’t reflect it—and one major reason is that the industry has been evaluating AM against a standard that was never designed to capture what AM actually changes,” said Sherri Monroe, Executive Director of AMGTA. “This report is the result of six years of watching that gap play out across industries, applications, and geographies. It is the argument the industry has needed and that only an organization with no commercial interest could make.”
“When I founded AMGTA, the goal was to create something the industry didn’t have: an independent, non-commercial voice that could make the case for AM’s value in the rooms where the real decisions get made,” said Brian Neff, Chair of the AMGTA Board of Directors. “This report is that voice. It makes the argument we’ve been building toward—complete, rigorous, and designed to hold up under scrutiny from finance, procurement, and policy. This is what six years of membership made possible.”
The report is available at www.AMGTA.org. The companion Strategy 2030 document—What We Do and Why Membership Matters—is available to AMGTA members.
About the Additive Manufacturer Green Trade Association (AMGTA)
The Additive Manufacturing Green Trade Association (AMGTA) is the only global, independent organization focused exclusively on the intersection of additive manufacturing and resource-efficient manufacturing systems. Founded in 2019, AMGTA convenes technology developers, manufacturing users, and ecosystem partners across five continents to establish evidence-based understanding of where and how additive manufacturing strengthens resource and operational performance. AMGTA has no equipment to sell, no materials to promote, and no national interest to advance. www.AMGTA.org
View source version on businesswire.com: https://www.businesswire.com/news/home/20260415976875/en/
Contacts
Media Contact:
Sherri Monroe
Executive Director
smonroe@amgta.org
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press Release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press Release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that
2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press Release
The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen Chupka, executive vice president, National Association of Broadcasters. “This year’s Show reflects the accelerating pace of innovation and
2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press Release
The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen Chupka, executive vice president, National Association of Broadcasters. “This year’s Show reflects the accelerating pace of innovation and
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product17.4.2026 23:43:00 CEST | Press Release
The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes. The agency concluded that renewing the IQOS and HEETS MRTP authorizations is appropriate to promote public health and is expected to benefit the health of the population as a whole taking into account both users of tobacco products and persons who do not currently use tobacco products. “As the only company to have successfully secured and maintained MRTP authorizations for heated tobacco products in the U.S., we are confident that our science-based alternatives can help adult smokers transition away from combustible cigarettes,” said Stacey Kenned
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom